dihydroxyphenylalanine has been researched along with Precancerous Conditions in 2 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Precancerous Conditions: Pathological conditions that tend eventually to become malignant.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Halldin, MM | 1 |
Cook, WS | 1 |
Kawashima, T | 1 |
Crutcher, WA | 1 |
Fukuyama, K | 1 |
Shanin, AP | 1 |
1 review available for dihydroxyphenylalanine and Precancerous Conditions
Article | Year |
---|---|
[A review of the literature concerning the etiology, pathogenesis, histogenesis, clinical picture and treatment of skin melanomas during the past 5 years].
Topics: Carbon Isotopes; Dihydroxyphenylalanine; Golgi Apparatus; Humans; Melanoma; Mitochondria; Nevus; Nev | 1971 |
1 other study available for dihydroxyphenylalanine and Precancerous Conditions
Article | Year |
---|---|
Identification of 5-S-cysteinyldopa by high performance liquid chromatography in biopsies from patients with dysplastic melanocytic nevi.
Topics: Biopsy; Chromatography, High Pressure Liquid; Cysteinyldopa; Dihydroxyphenylalanine; Humans; Melanoc | 1987 |